Filing Details
- Accession Number:
- 0001209191-21-019850
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-11 17:19:01
- Reporting Period:
- 2021-03-09
- Accepted Time:
- 2021-03-11 17:19:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1674930 | Fulgent Genetics Inc. | FLGT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1183863 | C John Bolger | C/O Fulgent Genetics, Inc. 4978 Santa Anita Ave. Temple City CA 91780 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-09 | 937 | $3.93 | 1,312 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-03-09 | 2,187 | $5.81 | 3,499 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-03-09 | 3,374 | $101.62 | 125 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-03-09 | 937 | $0.00 | 937 | $3.93 |
| Common Stock | Stock Options (Right to Buy) | Disposition | 2021-03-09 | 2,187 | $0.00 | 2,187 | $5.81 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,563 | 2028-05-18 | No | 4 | M | Direct | |
| 2,813 | 2029-05-30 | No | 4 | M | Direct |
Footnotes
- The shares were sold in multiple transactions at prices ranging from $100.5077 to $103.6447, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after May 18, 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
- The shares subject to the option vested over a period of four years, with 1/4th of such shares vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
Billionaire Hedge Funds
